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Warsaw Breakage Syndrome,
a Cohesinopathy Associated with Mutations
in the XPD Helicase Family Member DDX11/ChlR1
Petra van der Lelij,1 Krystyna H. Chrzanowska,2,* Barbara C. Godthelp,3 Martin A. Rooimans,1
Anneke B. Oostra,1 Markus Stumm,4 Ma1gorzata Z. Zdzienicka,5 Hans Joenje,1 and Johan P. de Winter1,*
The iron-sulfur-containing DNA helicases XPD, FANCJ, DDX11, and RTEL represent a small subclass of superfamily 2 helicases. XPD and
FANCJ have been connected to the genetic instability syndromes xeroderma pigmentosum and Fanconi anemia. Here, we report
a human individual with biallelic mutations in DDX11. Defective DDX11 is associated with a unique cellular phenotype in which
features of Fanconi anemia (drug-induced chromosomal breakage) and Roberts syndrome (sister chromatid cohesion defects) coexist.
The DDX11-deﬁcient patient represents another cohesinopathy, besides Cornelia de Lange syndrome and Roberts syndrome, and shows
that DDX11 functions at the interface between DNA repair and sister chromatid cohesion.Amale individual with severe microcephaly, pre- and post-
natal growth retardation, and abnormal skin pigmentation
(Figure 1 and Figure S1, available online) was suspected to
suffer from a chromosomal-instability syndrome. An
initial cytogenetic investigation on peripheral blood was
performed when the patient was one year old, and a
normal male karyotype was observed. The research on
patient material was carried out after approval by the insti-
tutional review board of the VUUniversity Medical Center,
adhered to local ethical standards, and was initiated only
after the relevant informed consent had been obtained.
Spontaneous and radiation-induced chromosomal insta-
bility as well as the frequency of spontaneous sister chro-
matid exchanges (SCEs) were within the normal range,
which effectively excluded ataxia telangiectasia (MIM
208900), Nijmegen breakage syndrome (MIM 251260),
and Bloom syndrome (MIM 210900) (data not shown).
To test for Fanconi anemia (FA [MIM 227650]), we exam-
ined fresh T lymphocyte cultures as well as EBV-immortal-
ized B lymphoblasts for mitomycin C (MMC)-induced
chromosomal breakage (Figure 2A and Figure S2). As
observed in cells from FA patients, strongly increased
breakage was detected in both cell types, supporting an
FA diagnosis. However, additional abnormalities in the
cohesion of sister chromatids were observed (Figures 2B
and 2C): chromosomes with centromeric cohesion defects
(‘‘railroads’’) and total ‘‘premature chromatid separation’’
(PCS). Strikingly, the percentage of metaphases showing
total PCS increased to 50%–60% upon exposure to the
DNA cross-linking agent MMC or the topoisomerase I
inhibitor camptothecin. Cohesion defects have not been
reported to occur in FA but are typical for the cohesinop-
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(Figure 2C). The affected individual thus appeared unique
in showing a combination of FA- and RBS-like cytogenetic
features; e.g., excessive drug-induced chromosomal
breakage and cohesion defects. The excessive susceptibili-
ties at the cytogenetic level were also observed in growth-
inhibition assays on lymphoblasts (Figure S3). Clonogenic
survival of skin ﬁbroblasts conﬁrmed MMC hypersensi-
tivity, whereas sensitivity to irradiation with X-rays or
ultraviolet C light was in the normal range (Figure S4).
This patient thus seemed to represent a novel cohesinop-
athy, with cellular features of both FA and RBS in associa-
tion with a distinct clinical phenotype.
Cohesion defects are not observed in any of the known
FA-complementation groups. Therefore, candidate genes
were sought for the affected individual, amongst those
for which a role in sister chromatid cohesion has been
described in the literature. Protein products from candi-
date genes were investigated by immunoblot analysis of
lymphoblast and ﬁbroblast lysates. This revealed normal
levels of the acetyltransferase ESCO2 (MIM 609353),
which is mutated in RBS.1 The related acetyltransferase
ESCO1 (MIM 609674) also appeared normal (Figure 3A).
Additional proteins, including SMC1 (MIM 300040),
SMC3 (MIM 606062), SMC5 (MIM 609386), SMC6 (MIM
609387), PDS5A (MIM 613200), PDS5B (MIM 605333),
CTF18 (MIM 613201), CTF4/AND-1 (MIM 608126), and
DDX11 (MIM 601150), were investigated, but no aberra-
tions in protein levels or mobility were observed (data
not shown), with the exception of the helicase DDX11,
which was barely detectable in ﬁbroblasts and lympho-
blasts from the affected individual (Figure 3A). Sequence
analysis of genomic DNA uncovered two mutations inechorststraat 7, NL-1081 BT Amsterdam, The Netherlands; 2Department of
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Figure 1. Characteristics of the Affected Individual
The patient is a male from Warsaw, Poland, with severe intra-
uterine growth retardation (weight 1300 g [< 3rd centile], length
38 cm [< 3rd centile ], and head circumference 25 cm [< 3rd cen-
tile] at 37 wks of gestation). Several congenital abnormalities
were found, including microcephaly, facial dysmorphy (small
and elongated face, narrow bifrontal diameter, jugular hypoplasia,
bilateral epicanthal folds, relatively large mouth, and cup-shaped
ears), high arched palate, coloboma of the right optic disc, deaf-
ness due to structural abnormalities of the inner ear (bilateral
hypoplastic cochlea), small ventricular septal defect, bilateral cli-
nodactyly of the ﬁfth ﬁngers, syndactyly of the second and third
toes, cutis marmorata, and one hypo- and three hyperpigmented
patches on the skin. Psychomotor and mental development
were mildly retarded. Growth was severely retarded (Figure S1).
Genitalia and pubertal development were normal. No malabsorp-
tion or pituitary or thyroid insufﬁciency was found. No hemato-
logical abnormalities, immunodeﬁciency, or malignancy were
noted either.DDX11 (MIM 601150): a splice-site mutation in intron 22
of the maternal allele (IVS22þ2T>C) and a 3 bp deletion
in exon 26 of the paternal allele (c.2689_2691del)
(Figure 3B). The splice-site mutation leads to a deletion
of the last 10 bp of exon 22 from the DDX11 cDNA
(Figure 3C), and the 3 bp deletion results in the deletion
of a highly conserved lysine residue in the DDX11 protein
(K897; Figure S5). Given the hardly detectable band on
immunoblot (Figure 3A), the mutant protein is probably
unstable. Introduction of DDX11 cDNA into lymphoblasts
from the affected individual (Figure 4A) rescued the
abnormal phenotype, in terms of both chromosomal
morphology (cohesion defect; Figure 4B) and sensitivity
to growth inhibition by MMC or camptothecin (Figures
4C and 4D). We conclude that the abnormal cellular
phenotype of the affected individual is causally related
to the mutations that we identiﬁed in DDX11. Sequence
analysis of six additional patients with a clinical pheno-The Americatype similar to that of the affected individual did not
reveal any additional examples of mutations in DDX11.
To our knowledge, this leaves the presented case as the ﬁrst
and only human example of a patient with a genetic
defect in DDX11.
DDX11 is the ortholog of yeast Chl1,2 and siRNA exper-
iments in human cells pointed to a role for DDX11 in
sister chromatid cohesion.3 Nevertheless, it was surprising
to ﬁnd DDX11 deﬁciency in humans, because Ddx11
knockout mice are lethal at embryonic day 10.5.4 The
mother of the affected individual had two miscarriages
(Figure 5), but no material was available for examination
of their possible association with biallelic mutations in
DDX11. Excessive aneuploidy, as observed in cells from
the Ddx11/ mice,4 was not observed in cultured
lymphocytes from the affected individual (Figure S6),
which could indicate that the affected cells may have
adapted to DDX11 deﬁciency or that some residual
DDX11 activity may still be present. The affected indi-
vidual, now 14.5 years old, has thus far not presented
with any malignancies, but his mother and grandmother,
both carriers of the splice-site mutation, have developed
Hodgkin lymphoma and adenocarcinoma of the endome-
trium, respectively (Figure 5). In addition, his great-grand-
mother developed cervical cancer and her sister devel-
oped uterine cancer. These data suggest that DDX11
may act as a tumor suppressor, which could be related
to the proposed role of DDX11 in viral genome mainte-
nance.5
DDX11 shares sequence similarity with FANCJ and the
related DEAH-box helicases XPD and RTEL,6 all of which
contain a unique iron-sulfur cluster between helicase
domain IA and II.7,8 FANCJ and XPD are connected to
the genetic-instability syndromes FA and xeroderma pig-
mentosum (MIM 278730), respectively, and their inactiva-
tion leads to an increased cancer risk. Here, we have shown
that inactivation of DDX11 causes a form of genetic insta-
bility that combines features observed in FA with those
seen in RBS. The DDX11-deﬁcient individual thus repre-
sents another example of a human cohesinopathy, besides
Cornelia de Lange syndrome (MIM 122470) and RBS. We
propose to name the syndrome associated with defective
DDX11 ‘‘Warsaw breakage syndrome’’ (WABS), in acknowl-
edgment of the origin of the identiﬁed individual with this
disorder, and to adopt WABS1 as an alias for DDX11. A
detailed insight into the clinical phenotype of WABS
awaits the identiﬁcation of additional patients. Given the
hypersensitivity of DDX11/WABS1-deﬁcient cells for
MMC and camptothecin, agents that both interfere with
DNA replication, DDX11/WABS1 may function at the
interface of replication-coupled DNA repair and sister
chromatid cohesion.Supplemental Data
Supplemental Data include six ﬁgures and can be found with this
article online at http://www.ajhg.org.n Journal of Human Genetics 86, 262–266, February 12, 2010 263
Figure 2. Chromosomal Breakage and
Cohesion Defects in Cells Derived from
the Affected Individual
(A) Chromosomal breakage after MMC
treatment of T lymphocyte cultures from
the affected individual (VU1202), his
mother, a healthy control, and an indi-
vidual with Fanconi anemia. Percentages
of cells with up to R 10 break events per
cell are indicated.
(B) Representative pictures of metaphases
with railroad chromosomes (RR) and total
premature chromatid separation (PCS).
(C) RR and PCS are frequently observed in
lymphoblasts from an individual with
Roberts syndrome and in those from the
affected individual. Percentages of cells
with normal chromosomes, RR, and PCS
are shown in untreated cells and in cells
treated for 48 hr with 150 nM MMC (M)
or 2.5 nM camptothecin (C). Patient
VU1177 is homozygous for c.1105insA in
ESCO2, and patient HSC72 is homozygous
for a deletion of exon18 to 28 in FANCA.
The ﬁgure shows the average of two exper-
iments with standard deviation.Acknowledgments
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Figure 3. DDX11 Mutations in the Affected Individual and His Parents
(A) Immunoblotting revealed normal ESCO1 and ESCO2 but hardly detectable DDX11 protein levels in lymphoblasts (VU1202-L) and
ﬁbroblasts (VU1202-F) from the affected individual.
(B) Sequence analysis on genomic DNA revealed the splice-site mutation IVS22þ2T>C in theDDX11 gene of the affected individual and
hismother (red arrow). In the paternal allele, a 3 bp deletionwas found (red arrow), which deleted a conserved lysine residue (K897) from
the DDX11 protein.
(C) Sequencing on cDNA of the affected individual showed that the splice-site mutation IVS22þ2T>C leads to a 10 bp deletion of exon
22 sequence from the DDX11 cDNA, resulting in a frameshift at codon 754 and a premature stop at codon 763.Web Resources
The URL for data presented herein is as follows:
Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/Omim/
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Figure 4. DDX11 Deficiency Underlies the Abnormal Cellular
Phenotype in the Affected Individual
(A–D) Two independent transfections of DDX11 cDNA into
lymphoblasts of patient VU1202 (A) restored normal DDX11
protein levels and chromosomal cohesion defects (B), as well as
hypersensitivity to growth inhibition by MMC (C) and campto-
thecin (D). (C) and (D) show the average of two independent
experiments, with the standard error of the mean shown.
Figure 5. Pedigree of the Affected Individual and Cancer Incidence in the Family
(A) Pedigree of the affected individual (V:3). The mother of the patient (IV:2) had twomiscarriages in the ﬁrst trimester (V:1 and V:2) and
developed Hodgkin lymphoma (HL) at age 33. The patient’s grandmother (III:2), also a carrier of the splice-site mutation IVS22þ2T>C,
was diagnosed with an adenocarcinoma of the endometrium (AE) at the age of 62. The patient’s great-grandmother (II:2) was diagnosed
with cervical cancer (CC) at age 56, and her sister (II:3) was diagnosed with uterine cancer (UC). Of the latter two cases, theDDX11muta-
tion status is unknown. There is no evidence for cancer predisposition in the family of the father.
(B) The splice-site mutation IVS22þ2T>C was detected in the tumors of the mother and grandmother.
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